Giulio Superti-furga
co-founder
Pediatric
Haplogen
Austria
Biography
Dr Superti-Furga is the scientific director of the Research Center for Molecular Medicine (CeMM) in Vienna, Austria. He obtained his PhD at the Institute for Molecular Pathology (IMP) in Austria, was a staff scientist at the European Molecular Biology Laboratory (EMBL) in Germany and the founding CSO of Cellzome AG, which was acquired by GSK for 61 million GBP in 2012. Giulio Superti-Furga has broad experience in the initiation and management of complex biology research and the systematic elucidation of the mechanism of action of drugs. Dr Superti-Furga is the scientific director of the Research Center for Molecular Medicine (CeMM) in Vienna, Austria. He obtained his PhD at the Institute for Molecular Pathology (IMP) in Austria, was a staff scientist at the European Molecular Biology Laboratory (EMBL) in Germany and the founding CSO of Cellzome AG, which was acquired by GSK for 61 million GBP in 2012. Giulio Superti-Furga has broad experience in the initiation and management of complex biology research and the systematic elucidation of the mechanism of action of drugs.
Research Interest
Pediatric Cardiology, Pediatric Neurology & Diseases, Pediatric & Neonatal Care
